Skip to content

Burden of ERCP; Preferences for treatment of common bile duct stones

Burden of ERCP; Preferences for treatment of common bile duct stones - BEP study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON31173
Enrollment
300
Registered
2007-09-21
Start date
2007-10-01
Completion date
Unknown
Last updated
2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

bile duct disease

Interventions

None listed

Sponsors

Erasmus MC, Universitair Medisch Centrum Rotterdam
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Part I: Burden of ERCP a) Patient is undergoing an ERCP at the Erasmus MC-University Medical Center Rotterdam or University Medical Center Utrecht b) Informed consent Part II: Patient preference for common bile duct stone (CBDS) treatment a) Patient is undergoing an ERCP for CBDS b) Patient is referred from the Erasmus MC-University Medical Center Rotterdam or University Medical Center Utrecht c) Patient participates in Part I d) Informed consent

Exclusion criteria

Exclusion criteria: Part I: Burden of ERCP a) Patient is referred from another hospital b) Not being able to fill out the questionnaire Part II: Patient preference for CBDS treatment a) Patient is referred from another hospital b) Not able to fill in the questionnaire c) Comorbid disease (e.g. malignancy, terminal illness, WHO performance score of 4)

Design outcomes

Primary

MeasureTime frame
Part I: Burden of ERCP Part II: Patient preferences for CBDS treatment

Secondary

MeasureTime frame
Part I: Physical symptoms (throat ache, nausea etc), quality of life and functional results (Bilirubine, ALAT, ASAT etc). Part II: The relevance and importance of determinants of patient preferences for CBDS treatment (characteristics of the treatment options, and respondent characteristics)

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)